Drug-Price Policy Discussions Are Focus Of MedPAC, Pew, Oncologists

By John Wilkerson / April 6, 2016 at 8:33 PM
Congressional Medicare advisers are scheduled Thursday (April 7) to take up draft recommendations on policy changes to drug reimbursement in both Medicare Part D and Part B, and they'll discuss policies that change how cancer doctors are paid for the drugs they administer. A few days later, Pew will host an event on CMS' proposed Medicare Part B drug payment demonstration that has oncologists and drug makers up in arms. Community oncologists this week presented HHS officials with a study...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.